PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-42

  1. 763 Posts.
    lightbulb Created with Sketch. 141
    So, in reality, PAR needed outstanding results to be able to negotiate a JV partner for further development in the MPS VI sector and to get an upfront payment. The results released today don't indicate that this is likely now.
    So it passed safety, minimally reduced pain and increased mobility, and ultimately has now helped to drive another nail in Paradigm's coffin by not helping to get a JV partner and desperately needed funds for the OA program.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.